Amerise Biosciences Limited, a active public limited company, was established on 27 August 1984 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: L29199GJ1984PLC007195. Registered under ROC Roc Ahmedabad. it is listed on BSE: 531681. It has an authorized capital of ₹7.50 Cr and a paid-up capital of ₹6.61 Cr.
Formerly known as Amradeep Industries Limited. It upholds a compliant status. In 2023, it reported revenue of ₹87.58 K and a net worth of ₹5.52 Cr. Its leadership includes Manisha Patel Maneklal (Director), Dineshkumar Tribhovanbhai Rathod (Whole-Time Director), Kelash Bunkar (Additional Director). Past directors included Nileshkumar Tribhovandas Kava, Anand Ramanlal Trivedi, Ganpat Motiram Rawal. It holds ₹3.84 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 24, Laxmi Chambers, Navjeevan Press Road, Opp. Old Gujarat High Court,, Ahmedabad, Gujarat, 380014.
L29199GJ1984PLC007195
007195
27 August 1984
₹7.50 Cr
₹6.61 Cr
Roc Ahmedabad
Listed (BSE: 531681)
Active
Explore comprehensive insights into Amerise Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manisha Patel Maneklal | Director | 24 Jun 2019 | Current |
| Dineshkumar Tribhovanbhai Rathod | Whole-Time Director | 22 Nov 2021 | Current |
| Kelash Bunkar | Additional Director | 03 Feb 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Aug 2014 | Past |
| Pramod Abcsdd | Director | 18 Dec 2009 | Past |
| Pramod Abcsdd | Director | 31 Mar 2008 | Past |
| Pramod Abcsdd | Director | 19 Mar 2019 | Past |
| Pramod Abcsdd | Director | 15 Jul 2009 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amerise Biosciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.91% decrease. The company also saw a substantial fall in profitability, with a 121.65% decrease in profit. The company's net worth dipped by a decrease of 2.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Amerise Biosciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,839,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 1987 | Bank Of Baroda | ₹0.90 M | Open |
| 20 Aug 1985 | Gujarat State Financial Corporation | ₹2.94 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amerise Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amerise Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amerise Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kelash Bunkar was appointed as a Additional Director was appointed as a Additional Director on 03 Feb 2025 & has been associated with this company since 9 months 22 days . was completed.
Progress on Amerise Biosciences Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Amerise Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on Dineshkumar Tribhovanbhai Rathod was appointed as a Whole-time director was appointed as a Whole-time director on 22 Nov 2021 & has been associated with this company since 4 years 3 days . was documented.
The activity Dineshkumar Tribhovanbhai Rathod was appointed as a CFO was appointed as a CFO on 22 Nov 2021 & has been associated with this company since 4 years 3 days . was completed.
The activity Minal Vinodkumar Lakhlani was appointed as a Company Secretary was appointed as a Company Secretary on 12 Nov 2021 & has been associated with this company since 4 years 13 days . was completed.
The CIN of Amerise Biosciences Limited is L29199GJ1984PLC007195.
Amerise Biosciences Limited is headquartered at 24, Laxmi Chambers, Navjeevan Press Road, Opp. Old Gujarat High Court,, Ahmedabad, Gujarat, 380014.
Amerise Biosciences Limited was incorporated on 27 August 1984.
The current directors of Amerise Biosciences Limited are
The primary industry of Amerise Biosciences Limited is Trade.
Amerise Biosciences Limited is listed. It is listed on BSE: 531681.
The authorized capital of Amerise Biosciences Limited is ₹7.50 Cr, and the paid-up capital is ₹6.61 Cr.
The compliance status of Amerise Biosciences Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX